Maryam Oskoui

NMD4C investigator Dr Maryam Oskoui profile picture

Investigator

Pediatric Neurologist, Neurophysiologist and Epidemiologist, Montreal Children’s Hospital

Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre


NMD4C Involvement: Pillar 2: Clinical Research

Email Maryam

Biography

Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Distinguished Clinical Research Scholar of the Fonds de Recherche Quebec with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR. 

 

Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and is past chair of the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec 

 

Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University. 


Recent Publications

Kwon, JM, Munell, F, Le Goff, L, Yuge, K, Kato, T, Cances, C et al.. Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nat Med. 2026. PMID:41606122

Socha, PM, Oskoui, M, Hutcheon, JA, Harper, S. A multivariable model for improving the identification of cerebral palsy cases in administrative health data. Ann Epidemiol. 2026.114 26-31 PMID:41539408

Tolchin, B, Goldstein, LH, Reuber, M, Stone, J, Perez, DL, LaFrance, WC Jr et al.. Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology. 2026.106 (1)e214466 PMID:41370742

Kwon, JM, Munell, F, Le Goff, L, Yuge, K, Kato, T, Cances, C et al.. Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nat Med. 2025. PMID:41360995

Groulx-Boivin, E, Belzile, A, Nguyen, CÉ, Gauthier, A, Chrestian, N, Michaud-Gosselin, C et al.. Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience. Int J Neonatal Screen. 2025.11 (4) PMID:41133701

See more on PubMed